These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23116743)

  • 41. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
    Mocroft A; Staszewski S; Weber R; Gatell J; Rockstroh J; Gasiorowski J; Panos G; Monforte Ad; Rakhmanova A; Phillips AN; Lundgren JD;
    Antivir Ther; 2007; 12(3):325-33. PubMed ID: 17591022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort.
    Patel AK; Pujari S; Patel K; Patel J; Shah N; Patel B; Gupte N
    J Assoc Physicians India; 2006 Dec; 54():915-8. PubMed ID: 17334006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a systematic review and meta-analysis.
    Jiang HY; Zhang MN; Chen HJ; Yang Y; Deng M; Ruan B
    Int J Infect Dis; 2014 Aug; 25():130-5. PubMed ID: 24911886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
    Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
    BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole.
    Manosuthi W; Athichathanabadi C; Uttayamakul S; Phoorisri T; Sungkanuparph S
    BMC Infect Dis; 2007 Mar; 7():14. PubMed ID: 17352798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or less.
    Ferrer E; Santamariña E; Domingo P; Fumero E; Ribera E; Knobel H; Lopez JC; Barrios A; Podzamczer D
    AIDS; 2004 Aug; 18(12):1727-9. PubMed ID: 15280785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients.
    Zhou HY; Zheng YH; He Y; Chen Z; Liu M; Yin W; Liu C
    Intervirology; 2010; 53(4):240-6. PubMed ID: 20357493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy.
    Lyons F; Hopkins S; Kelleher B; McGeary A; Sheehan G; Geoghegan J; Bergin C; Mulcahy FM; McCormick PA
    HIV Med; 2006 May; 7(4):255-60. PubMed ID: 16630038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.
    Keiser P; Nassar N; White C; Koen G; Moreno S
    HIV Clin Trials; 2002; 3(4):296-303. PubMed ID: 12187503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.
    van Leth F; Phanuphak P; Stroes E; Gazzard B; Cahn P; Raffi F; Wood R; Bloch M; Katlama C; Kastelein JJ; Schechter M; Murphy RL; Horban A; Hall DB; Lange JM; Reiss P
    PLoS Med; 2004 Oct; 1(1):e19. PubMed ID: 15526045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety issues about nevirapine administration in HIV-infected pregnant women.
    Manfredi R; Calza L
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):365-8. PubMed ID: 17592340
    [No Abstract]   [Full Text] [Related]  

  • 53. The interaction of CD4 T-cell count and nevirapine hepatotoxicity in China: a change in national treatment guidelines may be warranted.
    Zhang C; Wang W; Zhou M; Han Y; Xie J; Qiu Z; Guo F; Li Y; Wang H; Ghanem KG; Li T
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):540-5. PubMed ID: 23288032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004-2009.
    Mayanja BN; Shafer LA; Van der Paal L; Kyakuwa N; Ndembi N; Hughes P; Maher D; Grosskurth H
    Trop Med Int Health; 2012 Mar; 17(3):343-52. PubMed ID: 22212561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings.
    Kiertiburanakul S; Sungkanuparph S; Charoenyingwattana A; Mahasirimongkol S; Sura T; Chantratita W
    Curr HIV Res; 2008 Jan; 6(1):65-9. PubMed ID: 18288977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus.
    Tedaldi E; Willard S; Gilmore J; Holdsworth C; Dix-Lassiter S; Axelrod P
    J Assoc Nurses AIDS Care; 2002; 13(1):60-5. PubMed ID: 11828860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.
    Heffron R; Donnell D; Kiarie J; Rees H; Ngure K; Mugo N; Were E; Celum C; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):231-6. PubMed ID: 24442226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological markers in HIV-infected pregnant and non-pregnant women.
    Vimercati A; Greco P; Lopalco PL; Loverro G; Fiore JR; Bettocchi S; Angarano G; Selvaggi L
    Eur J Obstet Gynecol Reprod Biol; 2000 May; 90(1):37-41. PubMed ID: 10767508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy and HIV disease progression: a systematic review and meta-analysis.
    Calvert C; Ronsmans C
    Trop Med Int Health; 2015 Feb; 20(2):122-45. PubMed ID: 25358498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia.
    Stoner MC; Vwalika B; Smid MC; George S; Chi BH; Stringer EM; Stringer JS
    Int J Gynaecol Obstet; 2016 Sep; 134(3):299-303. PubMed ID: 27365290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.